Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)

Ceribell (CBLL) posted Liabilities and Shareholders Equity of $178.1 million for Q1 2026, down 9.05% on a QoQ basis from $195.8 million in Q4 2025, and down 16.58% year-over-year from $213.5 million in Q1 2025.

Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Ceribell's Liabilities and Shareholders Equity history runs 4 years deep, the most recent figure standing at $178.1 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 16.58% year-over-year to $178.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $781.1 million (up 60.74% YoY) and the FY2025 annual result came in at $195.8 million, down 13.14% from the prior year.
  • Liabilities and Shareholders Equity was $178.1 million for Q1 2026 at Ceribell, down from $195.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $225.4 million in Q4 2024 and bottomed at $47.1 million in Q3 2024.
  • A 4-year average of $165.7 million and a median of $197.7 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 323.99% — and 2026, when it declined 16.58%.
  • Ceribell's Liabilities and Shareholders Equity stood at $58.9 million in 2023, then surged by 282.56% to $225.4 million in 2024, then dropped by 13.14% to $195.8 million in 2025, then fell by 9.05% to $178.1 million in 2026.
  • Business Quant data shows CBLL's Liabilities and Shareholders Equity at $178.1 million in Q1 2026, $195.8 million in Q4 2025, and $199.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Ceribell 613.16 Mn 471.97 Mn 23.12 Mn 178.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 178.08 Mn
Dec 31, 2025 195.80 Mn
Sep 30, 2025 199.53 Mn
Jun 30, 2025 207.69 Mn
Mar 31, 2025 213.47 Mn
Dec 31, 2024 225.41 Mn
Sep 30, 2024 47.06 Mn
Dec 31, 2023 58.92 Mn